Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer.
Lawrence B, Blenkiron C, Parker K, Tsai P, Fitzgerald S, Shields P, Robb T, Yeong ML, Kramer N, James S, Black M, Fan V, Poonawala N, Yap P, Coats E, Woodhouse B, Ramsaroop R, Yozu M, Robinson B, Henare K, Koea J, Johnston P, Carroll R, Connor S, Morrin H, Elston M, Jackson C, Reid P, Windsor J, MacCormick A, Babor R, Bartlett A, Damianovich D, Knowlton N, Grimmond S, Findlay M, Print C.
Lawrence B, et al. Among authors: robinson b.
NPJ Genom Med. 2018 Jul 20;3:18. doi: 10.1038/s41525-018-0058-3. eCollection 2018.
NPJ Genom Med. 2018.
PMID: 30062048
Free PMC article.